Childhood eczema prevalence in New Zealand using topical corticosteroid dispensing data
Objectives To determine the prevalence of eczema among children in New Zealand. Methods Population‐based retrospective observational study utilising national pharmaceutical dispensing records for topical corticosteroids and emollients for all New Zealand children aged 0–14 years from 1st January 200...
Gespeichert in:
| Veröffentlicht in: | Australasian journal of dermatology 2024-11, Vol.65 (7), p.576-584 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 584 |
|---|---|
| container_issue | 7 |
| container_start_page | 576 |
| container_title | Australasian journal of dermatology |
| container_volume | 65 |
| creator | Harvey, Georgina Purvis, Diana J. Thompson, John M. D. Haskell, Libby Kennedy, Harriet Hoare, Karen Dalziel, Stuart R. |
| description | Objectives
To determine the prevalence of eczema among children in New Zealand.
Methods
Population‐based retrospective observational study utilising national pharmaceutical dispensing records for topical corticosteroids and emollients for all New Zealand children aged 0–14 years from 1st January 2006 to 31st December 2019. Data are reported using descriptive statistics, with comparisons between ethnicities and socioeconomic quintiles undertaken with rate ratios.
Results
Based on dispensing data, the prevalence of eczema for New Zealand children aged 0–14 years in 2018 was 14.0% (95% CI 14.0%–14.1%), with prevalence decreasing in older age groups (children aged |
| doi_str_mv | 10.1111/ajd.14347 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3079957574</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3126386726</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2437-7b5c2ba1b0d5f76e8a5b1ccfcf1e07034efcc68ab85eb8c226af58205c6fd5493</originalsourceid><addsrcrecordid>eNp1kMFO3DAQQC1UBMuWAz9QWeqlPYQdx3acHNHS0iIEFyokLpZjT4pX2Ti1ExB8PYFdOFRiDjOXp6fRI-SIwTGbZmFW7pgJLtQOmTEhIIOqgE9kBgAiK3kJ--QgpRUA40zKPbLPKwBeCDEjN8s737q7EBxF-4RrQ_uI96bFziL1Hb3EB3qLpjWdo2Py3V86hN5b01Ib4uBtSAPG4B11PvXYvRLODOYz2W1Mm_Bwe-fkz88f18tf2cXV2e_lyUVmc8FVpmpp89qwGpxsVIGlkTWztrENQ1DABTbWFqWpS4l1afO8MI0sc5C2aJwUFZ-TbxtvH8O_EdOg1z5ZbKeHMYxJc1BVJZVUYkK__oeuwhi76TvNWV7wslDTnpPvG8rGkFLERvfRr0181Az0S2091davtSf2y9Y41mt07-Rb3glYbIAH3-LjxyZ9cn66UT4DMJOJXQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3126386726</pqid></control><display><type>article</type><title>Childhood eczema prevalence in New Zealand using topical corticosteroid dispensing data</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Harvey, Georgina ; Purvis, Diana J. ; Thompson, John M. D. ; Haskell, Libby ; Kennedy, Harriet ; Hoare, Karen ; Dalziel, Stuart R.</creator><creatorcontrib>Harvey, Georgina ; Purvis, Diana J. ; Thompson, John M. D. ; Haskell, Libby ; Kennedy, Harriet ; Hoare, Karen ; Dalziel, Stuart R.</creatorcontrib><description>Objectives
To determine the prevalence of eczema among children in New Zealand.
Methods
Population‐based retrospective observational study utilising national pharmaceutical dispensing records for topical corticosteroids and emollients for all New Zealand children aged 0–14 years from 1st January 2006 to 31st December 2019. Data are reported using descriptive statistics, with comparisons between ethnicities and socioeconomic quintiles undertaken with rate ratios.
Results
Based on dispensing data, the prevalence of eczema for New Zealand children aged 0–14 years in 2018 was 14.0% (95% CI 14.0%–14.1%), with prevalence decreasing in older age groups (children aged <1 year 26.0% (25.6%–26.4%); children aged 10–14 years 8.8% (8.7%–8.9%)). Prevalence was higher in Pacific children (23.6% (23.3%–24.0%)), but slightly lower in Māori children (13.2% (13.0%–13.3%)).
Conclusion
Eczema is a common condition affecting a considerable proportion of children in New Zealand. This study provides nationwide paediatric prevalence data for New Zealand, and highlights the increased burden of eczema in Pacific children. Inequity in dispensing of topical corticosteroids is postulated to explain the reduced rates found for Māori children compared to previous studies. These results support the need for further research to determine factors contributing to differing eczema prevalence rates in New Zealand.</description><identifier>ISSN: 0004-8380</identifier><identifier>ISSN: 1440-0960</identifier><identifier>EISSN: 1440-0960</identifier><identifier>DOI: 10.1111/ajd.14347</identifier><identifier>PMID: 39003644</identifier><language>eng</language><publisher>Australia: Wiley Subscription Services, Inc</publisher><subject>Administration, Topical ; Adolescent ; Adrenal Cortex Hormones - administration & dosage ; Adrenal Cortex Hormones - therapeutic use ; atopic dermatitis ; Child ; Child, Preschool ; Children ; Corticosteroids ; dispensing records ; Eczema ; Eczema - drug therapy ; Eczema - epidemiology ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Maori People ; New Zealand ; New Zealand - epidemiology ; Pacific Island People ; Paediatric prevalence ; Pediatrics ; Population studies ; Prevalence ; Retrospective Studies ; Steroids</subject><ispartof>Australasian journal of dermatology, 2024-11, Vol.65 (7), p.576-584</ispartof><rights>2024 Australasian College of Dermatologists.</rights><rights>Copyright © 2024 The Australasian College of Dermatologists</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2437-7b5c2ba1b0d5f76e8a5b1ccfcf1e07034efcc68ab85eb8c226af58205c6fd5493</cites><orcidid>0000-0002-3485-3293 ; 0000-0002-4501-2211</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fajd.14347$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fajd.14347$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39003644$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Harvey, Georgina</creatorcontrib><creatorcontrib>Purvis, Diana J.</creatorcontrib><creatorcontrib>Thompson, John M. D.</creatorcontrib><creatorcontrib>Haskell, Libby</creatorcontrib><creatorcontrib>Kennedy, Harriet</creatorcontrib><creatorcontrib>Hoare, Karen</creatorcontrib><creatorcontrib>Dalziel, Stuart R.</creatorcontrib><title>Childhood eczema prevalence in New Zealand using topical corticosteroid dispensing data</title><title>Australasian journal of dermatology</title><addtitle>Australas J Dermatol</addtitle><description>Objectives
To determine the prevalence of eczema among children in New Zealand.
Methods
Population‐based retrospective observational study utilising national pharmaceutical dispensing records for topical corticosteroids and emollients for all New Zealand children aged 0–14 years from 1st January 2006 to 31st December 2019. Data are reported using descriptive statistics, with comparisons between ethnicities and socioeconomic quintiles undertaken with rate ratios.
Results
Based on dispensing data, the prevalence of eczema for New Zealand children aged 0–14 years in 2018 was 14.0% (95% CI 14.0%–14.1%), with prevalence decreasing in older age groups (children aged <1 year 26.0% (25.6%–26.4%); children aged 10–14 years 8.8% (8.7%–8.9%)). Prevalence was higher in Pacific children (23.6% (23.3%–24.0%)), but slightly lower in Māori children (13.2% (13.0%–13.3%)).
Conclusion
Eczema is a common condition affecting a considerable proportion of children in New Zealand. This study provides nationwide paediatric prevalence data for New Zealand, and highlights the increased burden of eczema in Pacific children. Inequity in dispensing of topical corticosteroids is postulated to explain the reduced rates found for Māori children compared to previous studies. These results support the need for further research to determine factors contributing to differing eczema prevalence rates in New Zealand.</description><subject>Administration, Topical</subject><subject>Adolescent</subject><subject>Adrenal Cortex Hormones - administration & dosage</subject><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>atopic dermatitis</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Corticosteroids</subject><subject>dispensing records</subject><subject>Eczema</subject><subject>Eczema - drug therapy</subject><subject>Eczema - epidemiology</subject><subject>Female</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Male</subject><subject>Maori People</subject><subject>New Zealand</subject><subject>New Zealand - epidemiology</subject><subject>Pacific Island People</subject><subject>Paediatric prevalence</subject><subject>Pediatrics</subject><subject>Population studies</subject><subject>Prevalence</subject><subject>Retrospective Studies</subject><subject>Steroids</subject><issn>0004-8380</issn><issn>1440-0960</issn><issn>1440-0960</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMFO3DAQQC1UBMuWAz9QWeqlPYQdx3acHNHS0iIEFyokLpZjT4pX2Ti1ExB8PYFdOFRiDjOXp6fRI-SIwTGbZmFW7pgJLtQOmTEhIIOqgE9kBgAiK3kJ--QgpRUA40zKPbLPKwBeCDEjN8s737q7EBxF-4RrQ_uI96bFziL1Hb3EB3qLpjWdo2Py3V86hN5b01Ib4uBtSAPG4B11PvXYvRLODOYz2W1Mm_Bwe-fkz88f18tf2cXV2e_lyUVmc8FVpmpp89qwGpxsVIGlkTWztrENQ1DABTbWFqWpS4l1afO8MI0sc5C2aJwUFZ-TbxtvH8O_EdOg1z5ZbKeHMYxJc1BVJZVUYkK__oeuwhi76TvNWV7wslDTnpPvG8rGkFLERvfRr0181Az0S2091davtSf2y9Y41mt07-Rb3glYbIAH3-LjxyZ9cn66UT4DMJOJXQ</recordid><startdate>202411</startdate><enddate>202411</enddate><creator>Harvey, Georgina</creator><creator>Purvis, Diana J.</creator><creator>Thompson, John M. D.</creator><creator>Haskell, Libby</creator><creator>Kennedy, Harriet</creator><creator>Hoare, Karen</creator><creator>Dalziel, Stuart R.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3485-3293</orcidid><orcidid>https://orcid.org/0000-0002-4501-2211</orcidid></search><sort><creationdate>202411</creationdate><title>Childhood eczema prevalence in New Zealand using topical corticosteroid dispensing data</title><author>Harvey, Georgina ; Purvis, Diana J. ; Thompson, John M. D. ; Haskell, Libby ; Kennedy, Harriet ; Hoare, Karen ; Dalziel, Stuart R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2437-7b5c2ba1b0d5f76e8a5b1ccfcf1e07034efcc68ab85eb8c226af58205c6fd5493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Administration, Topical</topic><topic>Adolescent</topic><topic>Adrenal Cortex Hormones - administration & dosage</topic><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>atopic dermatitis</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Corticosteroids</topic><topic>dispensing records</topic><topic>Eczema</topic><topic>Eczema - drug therapy</topic><topic>Eczema - epidemiology</topic><topic>Female</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Male</topic><topic>Maori People</topic><topic>New Zealand</topic><topic>New Zealand - epidemiology</topic><topic>Pacific Island People</topic><topic>Paediatric prevalence</topic><topic>Pediatrics</topic><topic>Population studies</topic><topic>Prevalence</topic><topic>Retrospective Studies</topic><topic>Steroids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Harvey, Georgina</creatorcontrib><creatorcontrib>Purvis, Diana J.</creatorcontrib><creatorcontrib>Thompson, John M. D.</creatorcontrib><creatorcontrib>Haskell, Libby</creatorcontrib><creatorcontrib>Kennedy, Harriet</creatorcontrib><creatorcontrib>Hoare, Karen</creatorcontrib><creatorcontrib>Dalziel, Stuart R.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Australasian journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Harvey, Georgina</au><au>Purvis, Diana J.</au><au>Thompson, John M. D.</au><au>Haskell, Libby</au><au>Kennedy, Harriet</au><au>Hoare, Karen</au><au>Dalziel, Stuart R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Childhood eczema prevalence in New Zealand using topical corticosteroid dispensing data</atitle><jtitle>Australasian journal of dermatology</jtitle><addtitle>Australas J Dermatol</addtitle><date>2024-11</date><risdate>2024</risdate><volume>65</volume><issue>7</issue><spage>576</spage><epage>584</epage><pages>576-584</pages><issn>0004-8380</issn><issn>1440-0960</issn><eissn>1440-0960</eissn><abstract>Objectives
To determine the prevalence of eczema among children in New Zealand.
Methods
Population‐based retrospective observational study utilising national pharmaceutical dispensing records for topical corticosteroids and emollients for all New Zealand children aged 0–14 years from 1st January 2006 to 31st December 2019. Data are reported using descriptive statistics, with comparisons between ethnicities and socioeconomic quintiles undertaken with rate ratios.
Results
Based on dispensing data, the prevalence of eczema for New Zealand children aged 0–14 years in 2018 was 14.0% (95% CI 14.0%–14.1%), with prevalence decreasing in older age groups (children aged <1 year 26.0% (25.6%–26.4%); children aged 10–14 years 8.8% (8.7%–8.9%)). Prevalence was higher in Pacific children (23.6% (23.3%–24.0%)), but slightly lower in Māori children (13.2% (13.0%–13.3%)).
Conclusion
Eczema is a common condition affecting a considerable proportion of children in New Zealand. This study provides nationwide paediatric prevalence data for New Zealand, and highlights the increased burden of eczema in Pacific children. Inequity in dispensing of topical corticosteroids is postulated to explain the reduced rates found for Māori children compared to previous studies. These results support the need for further research to determine factors contributing to differing eczema prevalence rates in New Zealand.</abstract><cop>Australia</cop><pub>Wiley Subscription Services, Inc</pub><pmid>39003644</pmid><doi>10.1111/ajd.14347</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-3485-3293</orcidid><orcidid>https://orcid.org/0000-0002-4501-2211</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0004-8380 |
| ispartof | Australasian journal of dermatology, 2024-11, Vol.65 (7), p.576-584 |
| issn | 0004-8380 1440-0960 1440-0960 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3079957574 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Administration, Topical Adolescent Adrenal Cortex Hormones - administration & dosage Adrenal Cortex Hormones - therapeutic use atopic dermatitis Child Child, Preschool Children Corticosteroids dispensing records Eczema Eczema - drug therapy Eczema - epidemiology Female Humans Infant Infant, Newborn Male Maori People New Zealand New Zealand - epidemiology Pacific Island People Paediatric prevalence Pediatrics Population studies Prevalence Retrospective Studies Steroids |
| title | Childhood eczema prevalence in New Zealand using topical corticosteroid dispensing data |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T19%3A52%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Childhood%20eczema%20prevalence%20in%20New%20Zealand%20using%20topical%20corticosteroid%20dispensing%20data&rft.jtitle=Australasian%20journal%20of%20dermatology&rft.au=Harvey,%20Georgina&rft.date=2024-11&rft.volume=65&rft.issue=7&rft.spage=576&rft.epage=584&rft.pages=576-584&rft.issn=0004-8380&rft.eissn=1440-0960&rft_id=info:doi/10.1111/ajd.14347&rft_dat=%3Cproquest_cross%3E3126386726%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3126386726&rft_id=info:pmid/39003644&rfr_iscdi=true |